Description A 4X blend of GHRP-2 (5mg), Tesamorelin (5mg), MGF (500mcg), and Ipamorelin (2.5mg) studied for its role in regulating growth hormone (GH) secretion and cellular processes. GHRP-2 has been researched for its ability to influence GH release and related biological pathways. Tesamorelin has been explored for its effects on GH secretion and lipid metabolism. MGF (Mechano Growth Factor) has been studied for its role in cellular signaling and tissue research. Ipamorelin interacts with the ghrelin receptor, influencing GH secretion while minimizing interactions with other endocrine pathways. This combination is commonly used in controlled research settings to evaluate GH-related responses and cellular mechanisms.
